Implementation of postgenomic technologies for cancer research. Institutional experience

by Martina RUDGALVYTĖ, Diana STANČIŪTĖ, Kristina BIELSKIENĖ, Violeta JONUŠIENĖ, Vida KIRVELIENĖ, Kęstutis SUŽIEDĖLIS, Vydmantas ATKOČIUS, Konstantinas Povilas VALUCKAS
Published 2010-07-01

The design of a new Cancer Research Institute and Laboratories for Durban.

by Du Plessis, Louis Stephen.
Published 2011

Cancer Research Institute, Tomsk National Research Medical Center of the RAS

by E. L. Choynzonov, Т. Ya. Kucherova, I. N. Udintseva, Т. V. Serebrov, V. A. Novikov, А. I. Ryabova, P. V. Surkova, O. V. Cheremisina, E. A. Sokolova
Published 2019-07-01

INFORMATION ON THE WORK OF DISSERTATION BOARD OF THE TOMSK CANCER RESEARCH INSTITUTE IN 2014

by I. Frolova
Published 2016-02-01

Science, institutional archives and open access: an overview and a pilot survey on the Italian cancer research institutions

by Mazzocut Mauro, Castelli Mauro, Di Benedetto Corrado, Truccolo Ivana, Poltronieri Elisabetta, Cognetti Gaetana
Published 2010-12-01

Characterization of the food intake and nutritional profile of oral cavity cancer survivors and the adherence degree to cancer prevention recommendations issued by the World Cancer Research Fund and the American Institute for Cancer Research Institute

by Gislaine Barbosa Bezerra, Renata Brum Martucci, Cristiane Ferreira Rodrigues
Published 2021-01-01

The use of digital pathology and image analysis in clinical trials

by Robert Pell, Karin Oien, Max Robinson, Helen Pitman, Nasir Rajpoot, Jens Rittscher, David Snead, Clare Verrill, on behalf of the UK National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) quality assurance working group
Published 2019-04-01

Training and accreditation standards for pathologists undertaking clinical trial work

by Gabrielle Rees, Manuel Salto‐Tellez, Jessica L Lee, Karin Oien, Clare Verrill, Alex Freeman, Ilaria Mirabile, Nicholas P West, on behalf of the National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) clinical trials working group
Published 2019-04-01

Involving young people in BRIGHTLIGHT from study inception to secondary data analysis: insights from 10 years of user involvement

by Rachel M. Taylor, Jeremy S. Whelan, Faith Gibson, Sue Morgan, Lorna A. Fern, on behalf of the BRIGHTLIGHT Team, Young Advisory Panel (YAP), Core Consumer Group (CCG) and National Cancer Research Institute Teenage and Young Adult Clinical Studies Group (NCRI TYA CSG)
Published 2018-12-01

Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work

by Max Robinson, Jacqueline James, Gareth Thomas, Nicholas West, Louise Jones, Jessica Lee, Karin Oien, Alex Freeman, Clare Craig, Philip Sloan, Philip Elliot, Maggie Cheang, Manuel Rodriguez‐Justo, Clare Verrill, on behalf of the UK National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) clinical trials working group
Published 2019-04-01

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

by Surein Arulananda, Megan O’Brien, Marco Evangelista, Tiffany J. Harris, Nikita S. Steinohrt, Laura J. Jenkins, Marzena Walkiewicz, Robert J. J. O’Donoghue, Ashleigh R. Poh, Bibhusal Thapa, David S. Williams, Trishe Leong, John M. Mariadason, Xia Li, Jonathan Cebon, Erinna F. Lee, Thomas John, W. Douglas Fairlie
Published 2021-06-01

The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis

by Ricardo Romero-Moreno, Kimberly J. Curtis, Thomas R. Coughlin, Maria Cristina Miranda-Vergara, Shourik Dutta, Aishwarya Natarajan, Beth A. Facchine, Kristen M. Jackson, Lukas Nystrom, Jun Li, William Kaliney, Glen L. Niebur, Laurie E. Littlepage
Published 2019-09-01

Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity

by Mercedes Dávalos-Salas, Magdalene K. Montgomery, Camilla M. Reehorst, Rebecca Nightingale, Irvin Ng, Holly Anderton, Sheren Al-Obaidi, Analia Lesmana, Cameron M. Scott, Paul Ioannidis, Hina Kalra, Shivakumar Keerthikumar, Lars Tögel, Angela Rigopoulos, Sylvia J. Gong, David S. Williams, Prusoth Yoganantharaja, Kim Bell-Anderson, Suresh Mathivanan, Yann Gibert, Scott Hiebert, Andrew M. Scott, Matthew J. Watt, John M. Mariadason
Published 2019-11-01

IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation

by Fuqing Hu, Da Song, Yumeng Yan, Changsheng Huang, Chentao Shen, Jingqin Lan, Yaqi Chen, Anyi Liu, Qi Wu, Li Sun, Feng Xu, Fayong Hu, Lisheng Chen, Xuelai Luo, Yongdong Feng, Shengyou Huang, Junbo Hu, Guihua Wang
Published 2021-06-01

Cell-cell contact-induced gene editing/activation in mammalian cells using a synNotch-CRISPR/Cas9 system

by Hongxin Huang, Xin Zhang, Jie Lv, Hongcheng Yang, Xinlong Wang, Shufeng Ma, Ruoyang Shao, Xin Peng, Ying Lin, Zhili Rong
Published 2020-01-01

Gene activation in human cells using CRISPR/Cpf1-p300 and CRISPR/Cpf1-SunTag systems

by Xin Zhang, Wei Wang, Lin Shan, Le Han, Shufeng Ma, Yan Zhang, Bingtao Hao, Ying Lin, Zhili Rong
Published 2017-11-01

A multiparametric extraction method for Vn96-isolated plasma extracellular vesicles and cell-free DNA that enables multi-omic profiling

by Jeremy W. Roy, Catherine A. Taylor, Annie P. Beauregard, Surendar R. Dhadi, D. Craig Ayre, Sheena Fry, Simi Chacko, Gabriel Wajnberg, Andrew P. Joy, Ngoc-Nu Mai-Thi, Nicolas Crapoulet, David A. Barnett, Anirban Ghosh, Stephen M. Lewis, Rodney J. Ouellette
Published 2021-04-01

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

by Rong Wang, Tadaaki Yamada, Kenji Kita, Hirokazu Taniguchi, Sachiko Arai, Koji Fukuda, Minoru Terashima, Akihiko Ishimura, Akihiro Nishiyama, Azusa Tanimoto, Shinji Takeuchi, Koshiro Ohtsubo, Kaname Yamashita, Tomoyoshi Yamano, Akihiro Yoshimura, Koichi Takayama, Kyoichi Kaira, Yoshihiko Taniguchi, Shinji Atagi, Hisanori Uehara, Rikinari Hanayama, Isao Matsumoto, Xujun Han, Kunio Matsumoto, Wei Wang, Takeshi Suzuki, Seiji Yano
Published 2020-09-01

Author Correction: miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR–p-PI3K/AKT-c-JUN

by Mengyang Zhao, Rongcheng Luo, Yiyi Liu, Linyuan Gao, Zhaojian Fu, Qiaofen Fu, Xiaojun Luo, Yiyu Chen, Xiaojie Deng, Zixi Liang, Xin Li, Chao Cheng, Zhen Liu, Weiyi Fang
Published 2021-05-01

Correction to: Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase

by Jingxian Liu, Jinghong Yang, Yuhe Hou, Zhenwei Zhu, Jie He, Hao Zhao, Xidong Ye, Dengke Li, Zhaohui Wu, Zhongxi Huang, Bingtao Hao, Kaitai Yao
Published 2021-02-01